Am J Transplant, Volume 16, Suppl 3 Archives - Page 27 of 180 - ATC Abstracts

2016 American Transplant Congress
Effect of Modifying Life Support Withdrawal Practices on Outcomes of Donation After Circulatory Death in Liver Transplantation: A Meta-Analysis.
Y. Cao,^1,2 S. Shahrestani,³ H. Chew,^2,4 M. Crawford,⁵ P. Macdonald,^1,2,4 J. Laurence,^3,5,7 W. Hawthorne,^3,6 K. Dhital,^1,2,4 H. Pleass.^3,5,6
¹Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; ²Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; ³Sydney Medical School, University of Sydney, Sydney, NSW, Australia; ⁴Cardiac Transplant Unit, St. Vincent's Hospital, Sydney, NSW, Australia; ⁵Australian National Liver Transplant Unit, Royal Prince Alfred Hospital, Sydney, NSW, Australia; ⁶The Department of Surgery, Westmead Hospital, Sydney, NSW, Australia; ⁷Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Aim. Donor warm ischaemic time is identified as the main risk factor for poor outcomes in liver transplantation using donation after circulatory death (DCD) compared…
2016 American Transplant Congress
Quadruple Induction Regimen with Basiliximab, Everolimus, Mycophenolate and Very Low Dose Tacrolimus Improves Graft Function without Increase in the Incidence of Microvascular Inflammation or De Novo Donor Specific Antibody Compared to the Standard Triple Regimen.
M. Miura, H. Higashiyama.
Department of Urology and Renal Transplantation Surgery, Sapporo Hokuyu Hospital, Sapporo, Japan.
Objectives: Nephrotoxicity of calcineurin inhibitors (CNI) in kidney allografts has been a significant problem even with low exposure regimens. On the other hand, CNI-free regimen…
2016 American Transplant Congress
Everolimus and Low Dose Cyclosporine Immunosuppressive Regimen and Development of Anti HLA Donor Specific Antibodies.
E. Minetti,¹ L. Di Maria,¹ L. Caroti,¹ E. Buti,² P. Carta.¹
¹Nephrology unit, Careggi University Hospital, Florence, Italy; ²Nephrology Unit, Mayer Univerity Hospital, Florence, Italy.
Few data are available on the rate of de novo anti-HLA donor specific antibodies (DSA) with the use of everolimus in kidney transplant recipients.MaterialsWe selected…
2016 American Transplant Congress
The Impact of Donor Origin on Survival after Orthotopic Heart Transplantation.
O. Kiamanesh, A. Khosla, C. Imai, E. Johansson, S. Virani, M. Davis, A. Cheung, J. Bashir, B. Munt, A. Ignaszewski, A. Kaan, M. Toma.
University of British Columbia, Vancouver, BC, Canada.
BackgroundOrthotopic heart transplantation (OHT) is the gold standard for the management of select patients with end-stage heart failure, but limited by an ongoing organ donor…
2016 American Transplant Congress
Predicting Emergence of Anti-HLA Class I and II Antibodies by Time Dependent Phenomapping in Heart Transplant Patients.
M. Bakir, N. Jackson, E. Chang, D. Henriquez-Ticas, C.-H. Tseng, T. Khuu, J. Zhang, E. Reed, M. Deng, M. Cadeiras.
Cardiology, University of California-Los Angeles, Los Angeles, CA.
Purpose: The presence of circulating HLA antibodies which is termed allosensitization among heart transplant (HTx) candidates are associated with poorer posttransplant outcomes including increased morbidity…
2016 American Transplant Congress
The Importance of KDPI in Simultaneous Liver and Kidney Transplant.
E. Chan,¹ M. Hertl,¹ J. Perkins.²
¹General Surgery, Rush University Medical Center, Chicago, IL; ²Surgery, University of Washington, Seattle, WA.
Background: The use of the Donor Risk Index (DRI) in liver transplantation and the Kidney Donor Profile Index (KDPI) in kidney transplantation has been well…
2016 American Transplant Congress
The Impact of Kidney Donor Profile Index (KDPI) on Rates of Delayed Graft Function (DGF).
T. Zens, G. Leverson, R. Redfield, P. Chlebeck, L. Zitur, D. Kaufman, L. Fernandez.
Surgery, University of Wisconsin, Madison, WI.
Introduction: Delayed graft function (DGF) is the need for dialysis within the first 7 days after kidney transplantation. Immunologic and non-immunologic donor and recipient factors…
2016 American Transplant Congress
Young Recipients Receiving Kidneys from Older Donors Have Poorer Allograft Outcomes.
A. Wardle, M. Willicombe, D. Goodall, A. McLean, D. Taube.
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
Introduction: An increasing number of marginal donors are being used in order to expand the donor pool. Age is one of the major criteria in…
2016 American Transplant Congress
A Successful Approach to Kidney Transplantation in Patients with Secondary Hyperoxaluria.
J. Roodnat,¹ A. Mik-van Egmond,² W. Visser,² S. Berger,³ W. van der Meijden,⁴ F. Knauf,⁵ M. Agteren van,¹ M. Betjes,¹ E. Hoorn.¹
¹Internal Medicine, Erasmus MC, Rotterdam, Netherlands; ²Dietetics, Erasmus MC, Rotterdam, Netherlands; ³Internal Medicine, University Hospital, Groningen, Netherlands; ⁴Internal Medicine, Radboud University, Nijmegen, Netherlands; ⁵Nephrology and Hypertension, Friedrich-Alexander-Universität, Erlangen-Nürnberg, Germany.
Chronic oxalate nephropathy is observed secondary to enteric hyperoxaluria that is associated with malabsorption e.g. in short bowel syndrome. Kidney transplantation can be challenging given…
2016 American Transplant Congress
Role of Donor Hemodynamic Trajectory in Determining Graft Survival in Liver Transplantation from Donation After Circulatory Death Donors.
D. Firl, K. Hashimoto, C. O'Rourke, J. Fung, B. Eghtesad.
Cleveland Clinic, Cleveland.
This retrospective study of 87 donation after circulatory death (DCD) liver transplants from 2007-2015 tested the hypothesis that donor hemodynamic trajectory following withdrawal effects graft…